SLC2A1 and neoplasm: Additionally, silencing of KLF13 raised the protein levels of SH2B1, IRS1, GLUT1, PDK1, and LDHA in xenograft tumours, and KLF13 overexpression exhibited the reverse actions (Figure 4H).